|
JP3278273B2
(ja)
*
|
1993-12-17 |
2002-04-30 |
キヤノン株式会社 |
薬剤徐放性カプセル
|
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
|
EP0948538B1
(en)
|
1996-12-13 |
2008-06-11 |
Novartis Vaccines and Diagnostics, Inc. |
Analysis and separation of platelet-derived growth factor proteins
|
|
US5985214A
(en)
|
1997-05-16 |
1999-11-16 |
Aurora Biosciences Corporation |
Systems and methods for rapidly identifying useful chemicals in liquid samples
|
|
JP4467789B2
(ja)
|
1997-09-18 |
2010-05-26 |
パシラ ファーマシューティカルズ インコーポレーテッド |
持続放出性リポソーム麻酔組成物
|
|
CA2671261A1
(en)
|
1997-11-06 |
1999-05-20 |
Novartis Vaccines And Diagnostics S.R.L. |
Neisserial antigens
|
|
CA2309548A1
(en)
|
1997-11-14 |
1999-05-27 |
Skyepharma Inc. |
Production of multivesicular liposomes
|
|
BR9906927A
(pt)
|
1998-01-14 |
2001-11-20 |
Chiron Spa |
Proteìnas de neisseria meningitidis
|
|
NZ541361A
(en)
|
1998-05-01 |
2008-04-30 |
Inst Genomic Research |
Neisseria meningitidis antigens and compositions relating to SEQ ID Nos:2916, 2918 and 2920
|
|
EP1953229A3
(en)
|
1998-10-15 |
2008-12-24 |
Novartis Vaccines and Diagnostics, Inc. |
Metastatic breast and colon cancer regulated genes
|
|
DK1141331T3
(da)
|
1998-12-16 |
2009-01-05 |
Novartis Vaccines & Diagnostic |
Human cyclinafhængig kinase (hPNQALRE)
|
|
US7393823B1
(en)
|
1999-01-20 |
2008-07-01 |
Oregon Health And Science University |
HER-2 binding antagonists
|
|
US7625859B1
(en)
|
2000-02-16 |
2009-12-01 |
Oregon Health & Science University |
HER-2 binding antagonists
|
|
MXPA01010924A
(es)
|
1999-04-30 |
2002-05-06 |
Chiron Spa |
Antigenos de neisseria conservados.
|
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
|
EP2275553B1
(en)
|
1999-10-29 |
2015-05-13 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigenic peptides
|
|
AU1922101A
(en)
|
1999-11-18 |
2001-05-30 |
Chiron Corporation |
Human fgf-21 gene and gene expression products
|
|
ES2507100T3
(es)
|
2000-01-17 |
2014-10-14 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacuna OMV suplementada contra meningococo
|
|
EP1261638A2
(en)
|
2000-03-08 |
2002-12-04 |
Chiron Corporation |
Human fgf-23 gene and gene expression products
|
|
EP1950297A2
(en)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
|
|
US7700359B2
(en)
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
|
EP1953243B1
(en)
|
2000-06-15 |
2012-12-26 |
Novartis Vaccines and Diagnostics, Inc. |
Polynucleotides related to colon cancer
|
|
NZ560966A
(en)
|
2000-10-27 |
2010-06-25 |
Novartis Vaccines & Diagnostic |
Nucleic acids and proteins from streptococcus groups A & B
|
|
JP2004535765A
(ja)
|
2000-12-07 |
2004-12-02 |
カイロン コーポレイション |
前立腺癌においてアップレギュレートされた内因性レトロウイルス
|
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
|
WO2002081639A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
|
WO2002081641A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
|
AU2002258728A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
|
US7309783B2
(en)
|
2001-05-09 |
2007-12-18 |
The University Of Connecticut |
Mammalian early developmental regulator gene
|
|
KR20030022094A
(ko)
|
2001-05-24 |
2003-03-15 |
(주)휴먼디엔에이테크놀로지 |
모낭에 존재하는 새로운 제 2 케라티노사이트 성장인자유사체
|
|
CN100398551C
(zh)
|
2001-11-09 |
2008-07-02 |
乔治敦大学 |
新的血管内皮细胞生长抑制剂同种型
|
|
KR100982204B1
(ko)
|
2001-12-12 |
2010-09-14 |
노바티스 백신즈 앤드 다이아그노스틱스 에스.알.엘. |
클라미디아 트라코마티스에 대한 면역화
|
|
ES2323456T3
(es)
|
2002-01-08 |
2009-07-16 |
Novartis Vaccines And Diagnostics, Inc. |
Productos genicos diferencialmente expresados en celulas de pecho cancerosas y sus metodos de uso.
|
|
WO2003080808A2
(en)
|
2002-03-21 |
2003-10-02 |
Sagres Discovery, Inc. |
Novel compositions and methods in cancer
|
|
US7138512B2
(en)
|
2002-04-10 |
2006-11-21 |
Georgetown University |
Gene SHINC-2 and diagnostic and therapeutic uses thereof
|
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
|
US8518694B2
(en)
|
2002-06-13 |
2013-08-27 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV
|
|
US7135324B2
(en)
|
2002-09-04 |
2006-11-14 |
The University Of Connecticut |
Viral recombinases, related articles, and methods of use thereof
|
|
UA80447C2
(en)
|
2002-10-08 |
2007-09-25 |
|
Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic
|
|
DK2279746T3
(da)
|
2002-11-15 |
2013-11-25 |
Novartis Vaccines & Diagnostic |
Overfladeproteiner i neisseria meningitidis
|
|
CA2921578C
(en)
|
2002-12-24 |
2017-02-14 |
Rinat Neuroscience Corp. |
Anti-ngf antibodies and methods using same
|
|
US7569364B2
(en)
|
2002-12-24 |
2009-08-04 |
Pfizer Inc. |
Anti-NGF antibodies and methods using same
|
|
US9498530B2
(en)
|
2002-12-24 |
2016-11-22 |
Rinat Neuroscience Corp. |
Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
|
|
US20040170982A1
(en)
|
2003-02-14 |
2004-09-02 |
Morris David W. |
Novel therapeutic targets in cancer
|
|
US7767387B2
(en)
|
2003-06-13 |
2010-08-03 |
Sagres Discovery, Inc. |
Therapeutic targets in cancer
|
|
CA2516138A1
(en)
|
2003-02-14 |
2004-09-02 |
Sagres Discovery, Inc. |
Therapeutic gpcr targets in cancer
|
|
EP1594441B1
(en)
|
2003-02-19 |
2010-12-15 |
Rinat Neuroscience Corp. |
Method for treating pain by administering a nerve growth factor antagonist and an nsaid and composition containing the same
|
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
|
GB2388581A
(en)
|
2003-08-22 |
2003-11-19 |
Danisco |
Coated aqueous beads
|
|
DK1656026T3
(da)
|
2003-08-22 |
2014-07-14 |
Dupont Nutrition Biosci Aps |
Sammensætning, der omfatter et bakteriocin og et ekstrakt fra en plante fra læbeblomstfamilien
|
|
BRPI0417270A
(pt)
|
2003-12-23 |
2007-03-27 |
Rinat Neuroscience Corp |
anticorpos agonistas antitrkc e métodos para utilização dos mesmos
|
|
DK1736541T3
(da)
|
2004-03-29 |
2013-05-06 |
Galpharma Co Ltd |
Nyt modificeret galectin 9-protein og anvendelse heraf
|
|
KR20060135060A
(ko)
|
2004-04-07 |
2006-12-28 |
리나트 뉴로사이언스 코퍼레이션 |
신경성장인자 길항제의 투여에 의한 골암 통증의 치료방법
|
|
AU2005327194B2
(en)
|
2004-07-09 |
2010-09-09 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Soluble forms of Hendra and Nipah virus G glycoprotein
|
|
US20060024677A1
(en)
|
2004-07-20 |
2006-02-02 |
Morris David W |
Novel therapeutic targets in cancer
|
|
EP2298807A3
(en)
|
2004-07-30 |
2011-05-18 |
Rinat Neuroscience Corp. |
Antibodies directed against amyloid-beta peptide and methods using same
|
|
DE05852057T1
(de)
|
2004-11-23 |
2007-11-29 |
Neuromolecular Pharmaceuticals Inc., Emeryville |
Zusammensetzung aus einer beschichtung oder matrix mit verzögerter freisetzung und einem nmda-rezeptorantagonisten sowie verfahren zur verabreichung eines solchen nmda-rezeptorantagonisten an ein subjekt
|
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
|
WO2006058236A2
(en)
|
2004-11-24 |
2006-06-01 |
Neuromolecular Pharmaceuticals, Inc. |
Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease
|
|
US7939490B2
(en)
|
2004-12-13 |
2011-05-10 |
University Of Maryland, Baltimore |
TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death
|
|
EP1858919B1
(en)
|
2005-02-18 |
2012-04-04 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogens from uropathogenic escherichia coli
|
|
DE602006016934D1
(de)
|
2005-04-06 |
2010-10-28 |
Adamas Pharmaceuticals Inc |
Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen
|
|
WO2006110599A2
(en)
|
2005-04-07 |
2006-10-19 |
Novartis Vaccines And Diagnostics Inc. |
Cacna1e in cancer diagnosis, detection and treatment
|
|
JP2008535853A
(ja)
|
2005-04-07 |
2008-09-04 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド |
癌関連遺伝子
|
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
|
JP4997239B2
(ja)
|
2005-07-22 |
2012-08-08 |
ワイズ・エー・シー株式会社 |
抗ｃｄ２６抗体およびその使用方法
|
|
SI2380592T1
(en)
|
2005-11-14 |
2018-06-29 |
Teva Pharmaceuticals International Gmbh |
The antibody to the calcitonin-related peptide antagonist
|
|
JP2009525319A
(ja)
|
2006-02-02 |
2009-07-09 |
ライナット ニューロサイエンス コーポレイション |
ｔｒｋＢアンタゴニストを投与することにより肥満を治療する方法
|
|
SG172684A1
(en)
|
2006-06-07 |
2011-07-28 |
Bioalliance Cv |
Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
|
|
EP2035035A2
(en)
|
2006-06-09 |
2009-03-18 |
Novartis AG |
Immunogenic compositions for streptococcus agalactiae
|
|
JP2010500399A
(ja)
|
2006-08-16 |
2010-01-07 |
ノバルティス アーゲー |
尿路病原性大腸菌由来の免疫原
|
|
EP2134365B1
(en)
|
2007-03-21 |
2019-03-13 |
Effat Emamian |
Compositions and methods for inhibiting tumor cell growth
|
|
WO2008124176A2
(en)
|
2007-04-10 |
2008-10-16 |
The Administrators Of The Tulane Educational Fund |
Soluble and membrane-anchored forms of lassa virus subunit proteins
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
WO2009077993A2
(en)
|
2007-12-17 |
2009-06-25 |
Pfizer Limited |
Treatment of interstitial cystitis
|
|
ES2550757T3
(es)
|
2007-12-18 |
2015-11-12 |
Bioalliance C.V. |
Anticuerpos que reconocen un epítopo que contiene carbohidratos en CD43 y ACE expresados en células cancerosas y métodos de uso de los mismos
|
|
JP2011516078A
(ja)
|
2008-04-10 |
2011-05-26 |
セル・シグナリング・テクノロジー・インコーポレイテツド |
癌におけるｅｇｆｒ突然変異を検出する組成物および方法
|
|
WO2009150623A1
(en)
|
2008-06-13 |
2009-12-17 |
Pfizer Inc |
Treatment of chronic prostatitis
|
|
TWI516501B
(zh)
|
2008-09-12 |
2016-01-11 |
禮納特神經系統科學公司 |
Ｐｃｓｋ９拮抗劑類
|
|
WO2010086828A2
(en)
|
2009-02-02 |
2010-08-05 |
Rinat Neuroscience Corporation |
Agonist anti-trkb monoclonal antibodies
|
|
ES2733084T3
(es)
|
2009-03-06 |
2019-11-27 |
Glaxosmithkline Biologicals Sa |
Antígenos de Chlamydia
|
|
WO2010118243A2
(en)
|
2009-04-08 |
2010-10-14 |
Genentech, Inc. |
Use of il-27 antagonists to treat lupus
|
|
BRPI1013780B8
(pt)
|
2009-04-14 |
2022-10-04 |
Novartis Ag |
Composição imunogênica útil para imunização contra staphylococcus aureus, seu método de preparação e composição farmacêutica
|
|
WO2010146511A1
(en)
|
2009-06-17 |
2010-12-23 |
Pfizer Limited |
Treatment of overactive bladder
|
|
CA2767536A1
(en)
|
2009-07-07 |
2011-01-13 |
Novartis Ag |
Conserved escherichia coli immunogens
|
|
CA2768343A1
(en)
|
2009-07-16 |
2011-01-20 |
Novartis Ag |
Detoxified escherichia coli immunogens
|
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
|
AU2010325960C1
(en)
|
2009-12-02 |
2015-08-06 |
Adamas Pharma, Llc |
Amantadine compositions and methods of use
|
|
TWI596114B
(zh)
|
2010-02-24 |
2017-08-21 |
雷那特神經科學股份有限公司 |
拮抗劑抗-ｉｌ-７受體抗體及方法
|
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
|
MX2012010481A
(es)
|
2010-03-11 |
2012-10-09 |
Rinat Neuroscience Corp |
Anticuerpos con union de antigenos dependiente del ph.
|
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
|
US9770414B2
(en)
*
|
2010-05-13 |
2017-09-26 |
Pacira Pharmaceuticals, Inc. |
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent
|
|
JP2013533286A
(ja)
|
2010-07-30 |
2013-08-22 |
セントルイス ユニバーシティ |
疼痛を治療する方法
|
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
|
US20130071375A1
(en)
|
2011-08-22 |
2013-03-21 |
Saint Louis University |
Compositions and methods for treating inflammation
|
|
WO2013028527A1
(en)
|
2011-08-23 |
2013-02-28 |
Indiana University Research And Technology Corporation |
Compositions and methods for treating cancer
|
|
SG11201401699WA
(en)
|
2011-11-11 |
2014-09-26 |
Rinat Neuroscience Corp |
Antibodies specific for trop-2 and their uses
|
|
WO2013093693A1
(en)
|
2011-12-22 |
2013-06-27 |
Rinat Neuroscience Corp. |
Staphylococcus aureus specific antibodies and uses thereof
|
|
CN104169301A
(zh)
|
2011-12-22 |
2014-11-26 |
瑞纳神经科学公司 |
人生长激素受体拮抗剂抗体及其使用方法
|
|
US20150191702A1
(en)
|
2012-07-02 |
2015-07-09 |
Commonwealth Scientific And Industrial Research Organization |
Paramyxovirus and Methods of Use
|
|
US8603470B1
(en)
|
2012-08-07 |
2013-12-10 |
National Cheng Kung University |
Use of IL-20 antagonists for treating liver diseases
|
|
BR112015010722A2
(pt)
|
2012-11-09 |
2017-08-22 |
Pfizer |
Anticorpos específicos de fator de crescimento derivado de plaquetas de isoforma b e composições e usos dos mesmos
|
|
US20160017055A1
(en)
|
2013-03-15 |
2016-01-21 |
Dyax Corp. |
Anti-plasma kallikrein antibodies
|
|
CN105189560A
(zh)
|
2013-05-07 |
2015-12-23 |
瑞纳神经科学公司 |
抗胰高血糖素受体抗体和其使用方法
|
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
TWI623551B
(zh)
|
2013-08-02 |
2018-05-11 |
輝瑞大藥廠 |
抗ｃｘｃｒ４抗體及抗體－藥物結合物
|
|
SG10201810298VA
(en)
|
2013-11-13 |
2018-12-28 |
Pfizer |
Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof
|
|
WO2015087187A1
(en)
|
2013-12-10 |
2015-06-18 |
Rinat Neuroscience Corp. |
Anti-sclerostin antibodies
|
|
WO2015109212A1
(en)
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
|
PE20220337A1
(es)
|
2014-03-21 |
2022-03-14 |
Teva Pharmaceuticals Int Gmbh |
Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos
|
|
EP3139955B1
(en)
|
2014-04-30 |
2024-03-20 |
President and Fellows of Harvard College |
Fusion proteins for treating cancer and related methods
|
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
|
TWI595006B
(zh)
|
2014-12-09 |
2017-08-11 |
禮納特神經系統科學公司 |
抗ｐｄ－１抗體類和使用彼等之方法
|
|
US9758575B2
(en)
|
2015-04-06 |
2017-09-12 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof
|
|
TWI787645B
(zh)
|
2015-04-13 |
2022-12-21 |
美商輝瑞股份有限公司 |
Ｃｄ３特異性抗體、治療性雙特異性抗體及其用途
|
|
US10877045B2
(en)
|
2015-07-21 |
2020-12-29 |
Saint Louis University |
Compositions and methods for diagnosing and treating endometriosis-related infertility
|
|
MX2018000714A
(es)
|
2015-07-21 |
2019-11-18 |
Dyax Corp |
Un inhibidor de anticuerpo monoclonal de factor xiia.
|
|
US11066481B2
(en)
|
2015-07-23 |
2021-07-20 |
The Regents Of The University Of California |
Antibodies to coagulation factor XIa and uses thereof
|
|
KR20230074843A
(ko)
|
2015-08-19 |
2023-05-31 |
화이자 인코포레이티드 |
조직 인자 경로 억제제 항체 및 그의 용도
|
|
IL305148A
(en)
|
2015-09-15 |
2023-10-01 |
Scholar Rock Inc |
Anti-pro/hidden myostatin antibodies and their uses
|
|
JP6661319B2
(ja)
*
|
2015-09-28 |
2020-03-11 |
小林製薬株式会社 |
リポソーム
|
|
US10138298B2
(en)
|
2015-10-23 |
2018-11-27 |
The Regents Of The University Of California |
Anti-IL-2 antibodies and compositions and uses thereof
|
|
WO2017075037A1
(en)
|
2015-10-27 |
2017-05-04 |
Scholar Rock, Inc. |
Primed growth factors and uses thereof
|
|
CN106699889A
(zh)
|
2015-11-18 |
2017-05-24 |
礼进生物医药科技（上海）有限公司 |
抗pd-1抗体及其治疗用途
|
|
CA3010056A1
(en)
|
2015-12-30 |
2017-07-06 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
|
US10973783B2
(en)
|
2015-12-30 |
2021-04-13 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of seizure-related disorders
|
|
WO2017125831A1
(en)
|
2016-01-21 |
2017-07-27 |
Pfizer Inc. |
Mono and bispecific antibodies for epidermal growth factor receptor variant iii and cd3 and their uses
|
|
KR102069670B1
(ko)
*
|
2017-03-02 |
2020-01-23 |
단디바이오사이언스 주식회사 |
면역활성물질을 포함하는 다중도메인캡슐, 이의 제조방법, 및 이를 포함하는 면역조절 조성물
|
|
KR20190124753A
(ko)
|
2017-03-03 |
2019-11-05 |
리나트 뉴로사이언스 코프. |
항-gitr 항체 및 이의 사용 방법
|
|
US20200056190A1
(en)
|
2017-03-16 |
2020-02-20 |
Pfizer Inc. |
Tyrosine prototrophy
|
|
WO2018191548A2
(en)
|
2017-04-14 |
2018-10-18 |
Kodiak Sciences Inc. |
Complement factor d antagonist antibodies and conjugates thereof
|
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
|
PE20191846A1
(es)
|
2017-06-02 |
2019-12-31 |
Pfizer |
Anticuerpos especificos para flt3 y sus usos
|
|
WO2018231771A1
(en)
|
2017-06-13 |
2018-12-20 |
Bostongene Corporation |
Systems and methods for generating, visualizing and classifying molecular functional profiles
|
|
EP3651799A1
(en)
|
2017-07-13 |
2020-05-20 |
Massachusetts Institute of Technology |
Targeting the hdac2-sp3 complex to enhance synaptic function
|
|
WO2019016784A1
(en)
|
2017-07-21 |
2019-01-24 |
Universidade De Coimbra |
ANTI-NUCLEOLIN ANTIBODIES
|
|
WO2019070161A2
(en)
|
2017-10-04 |
2019-04-11 |
Opko Pharmaceuticals, Llc |
ARTICLES AND METHODS FOR PERSONALIZED THERAPY OF CANCER
|
|
AU2019215075A1
(en)
|
2018-02-01 |
2020-08-20 |
Pfizer Inc. |
Antibodies specific for CD70 and their uses
|
|
KR20200128018A
(ko)
|
2018-02-01 |
2020-11-11 |
화이자 인코포레이티드 |
Cd70을 표적으로 하는 키메라 항원 수용체
|
|
JP2021516045A
(ja)
|
2018-02-28 |
2021-07-01 |
ファイザー・インク |
Ｉｌ−１５バリアントおよびその使用
|
|
TWI793325B
(zh)
|
2018-05-23 |
2023-02-21 |
美商輝瑞大藥廠 |
對cd3具特異性之抗體及其用途
|
|
TWI816396B
(zh)
|
2018-05-23 |
2023-09-21 |
美商輝瑞大藥廠 |
特異性針對gucy2c之抗體及其用途
|
|
US20210005284A1
(en)
|
2019-07-03 |
2021-01-07 |
Bostongene Corporation |
Techniques for nucleic acid data quality control
|
|
EP4041308A1
(en)
|
2019-10-07 |
2022-08-17 |
University of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
|
EP4041312A4
(en)
|
2019-10-10 |
2023-12-20 |
Kodiak Sciences Inc. |
METHOD FOR TREATING AN EYE DISORDER
|
|
WO2021072244A1
(en)
|
2019-10-11 |
2021-04-15 |
Beth Israel Deaconess Medical Center, Inc. |
Anti-tn antibodies and uses thereof
|
|
EP4093426A1
(en)
|
2020-01-24 |
2022-11-30 |
University of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
|
WO2021205325A1
(en)
|
2020-04-08 |
2021-10-14 |
Pfizer Inc. |
Anti-gucy2c antibodies and uses thereof
|
|
WO2021224850A1
(en)
|
2020-05-06 |
2021-11-11 |
Crispr Therapeutics Ag |
Mask peptides and masked anti-ptk7 antibodies comprising such
|
|
AU2021308586A1
(en)
|
2020-07-17 |
2023-03-02 |
Pfizer Inc. |
Therapeutic antibodies and their uses
|
|
JP2023535604A
(ja)
|
2020-07-30 |
2023-08-18 |
ファイザー・インク |
遺伝子複製を有する細胞およびその使用
|
|
EP4203989A2
(en)
|
2020-09-03 |
2023-07-05 |
Rampart Bioscience, Inc. |
Soluble alkaline phosphatase constructs and expression vectors including a polynucleotide encoding for soluble alkaline phosphatase constructs
|
|
US20220180972A1
(en)
|
2020-12-04 |
2022-06-09 |
Bostongene Corporation |
Hierarchical machine learning techniques for identifying molecular categories from expression data
|
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
JP2024517745A
(ja)
|
2021-04-29 |
2024-04-23 |
ボストンジーン コーポレイション |
複合腫瘍組織における腫瘍細胞発現を推定するための機械学習技法
|
|
CA3227875A1
(en)
|
2021-08-02 |
2023-02-09 |
Pfizer Inc. |
Improved expression vectors and uses thereof
|
|
WO2023147177A1
(en)
|
2022-01-31 |
2023-08-03 |
Bostongene Corporation |
Machine learning techniques for cytometry
|
|
WO2023148598A1
(en)
|
2022-02-02 |
2023-08-10 |
Pfizer Inc. |
Cysteine prototrophy
|
|
WO2024015561A1
(en)
|
2022-07-15 |
2024-01-18 |
Bostongene Corporation |
Techniques for detecting homologous recombination deficiency (hrd)
|